New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it […]
Multiplex assay combines non-invasive biosensor measurement with live cell imaging SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE: A) today introduced a multimode real-time cell analyzer (RTCA)—the first of its kind—combining the best of non-invasive biosensor measurement with live cell imaging. “The xCELLigence RTCA eSight will revolutionize cell analysis in life science research,” said Todd Christian, Agilent vice president, and […]
The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., August 12, 2019 — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), […]
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™. This first-of-its-kind, miniature CE-MS-based analyzer lets biopharma researchers accelerate process development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime. The company is presenting the Rebel for the first […]
Bournemouth, UK: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with the current surge in the bioprocessing […]
Emeryville, California – Berkeley Lights, Inc. (BLI), a pioneer and leader in digital cell biology, today announced the appointment of Sarah Boyce, President of Akcea Therapeutics to the Berkeley Lights’ board of directors. Ms. Boyce brings over 25 years of commercial and clinical development expertise in the life sciences industry to this role along with a proven […]
Nucleus Biologics now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – Nucleus Biologics, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition of Primorigen’s Vitronectin XFTM and platform recombinant protein production technology will play a huge role in Nucleus’ strategy of offering traceable, reproducible and […]
New Funding, Anticipated to Close at $22 Million, to Fuel Growth of its Regenerative Medicine MSC Manufacturing Platform Worldwide, Scale the Organization, and Accelerate R&D Innovation Frederick, MD, Aug. 6 — RoosterBio Inc, disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing, today announced it has raised in excess of $15 million in an initial Series B financing […]
FREIBURG, Germany — The owners of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a stronger global presence are just some of […]
CELLINK AB (“CELLINK”) has entered an agreement with the owners of cytena GmbH (“cytena”) to acquire all cytena shares for a purchase price of 30.25M euros (“acquisition”). Through cytena’s complementary technology offering, CELLINK sees great synergies that will support future growth. cytena is the company CELLINK announced signing a LOI with in conjunction with raising capital in […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
